| Location: | Leeds |
|---|---|
| Salary: | £33,951 to £39,906 per annum |
| Hours: | Full Time |
| Contract Type: | Fixed-Term/Contract |
| Placed On: | 23rd July 2026 |
|---|---|
| Closes: | 17th August 2026 |
| Job Ref: | EPSCH1134 |
Contract type: Fixed Term (12 months - to complete specific time limited work)
Are you an early career researcher with an interest in research at the interface of chemistry, biology and medicine? Do you have a background in chemical biology or protein chemistry? Would you like to contribute to developing an early stage technology to prepare it for evaluation in future clinical applications?
In this project, you will be contribute to a new EIC-funded project, IMProGlyco, in which we are developing a new strategy to control protein glycosylation. You will be part of an international project including researchers in Leeds, York, Vienna, Oslo and Dublin developing this new technology. You will contribute to the project by developing the reagents at the core of the project and providing key materials to researchers across Europe.
We are open to discussing flexible working arrangements.
To explore the post further or for any queries you may have, please contact:
Professor Michael Webb, Professor of Biological Chemistry
Tel: +44 (0)113 343 6423
Email: M.E.Webb@leeds.ac.uk
Type / Role:
Subject Area(s):
Location(s):